Charles Schwab’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$496K Sell
1,510,076
-175,702
-10% -$276K ﹤0.01% 3106
2025
Q4
$5.23M Sell
1,685,778
-43,856
-3% -$125K ﹤0.01% 2432
2025
Q3
$4.55M Buy
1,729,634
+108,215
+7% +$239K ﹤0.01% 2482
2025
Q2
$1.99M Buy
1,621,419
+482,472
+42% +$526K ﹤0.01% 2671
2025
Q1
$1.25M Sell
1,138,947
-103,032
-8% -$119K ﹤0.01% 2767
2024
Q4
$1.12M Buy
1,241,979
+13,902
+1% +$11.9K ﹤0.01% 2877
2024
Q3
$1.21M Sell
1,228,077
-33,520
-3% -$32.2K ﹤0.01% 2861
2024
Q2
$1.14M Buy
1,261,597
+8,833
+0.7% +$6.61K ﹤0.01% 2885
2024
Q1
$1.48M Buy
1,252,764
+32,935
+3% +$36.3K ﹤0.01% 2677
2023
Q4
$1.11M Buy
1,219,829
+139,187
+13% +$103K ﹤0.01% 2794
2023
Q3
$900K Buy
1,080,642
+651,837
+152% +$751K ﹤0.01% 2833
2023
Q2
$515K Sell
428,805
-33,892
-7% -$42.2K ﹤0.01% 3042
2023
Q1
$583K Sell
462,697
-79,358
-15% -$152K ﹤0.01% 2902
2022
Q4
$1.18M Buy
542,055
+11,870
+2% +$97.7K ﹤0.01% 2727
2022
Q3
$6.35M Buy
530,185
+132,756
+33% +$1.65M ﹤0.01% 2096
2022
Q2
$3.33M Sell
397,429
-10,126
-2% -$78.5K ﹤0.01% 2367
2022
Q1
$3.54M Buy
407,555
+17,050
+4% +$164K ﹤0.01% 2444
2021
Q4
$4.42M Buy
390,505
+7,938
+2% +$94.3K ﹤0.01% 2408
2021
Q3
$4.81M Buy
382,567
+20,237
+6% +$186K ﹤0.01% 2396
2021
Q2
$2.94M Buy
362,330
+42,330
+13% +$367K ﹤0.01% 2593
2021
Q1
$2.96M Sell
320,000
-17,215
-5% -$174K ﹤0.01% 2538
2020
Q4
$3.26M Buy
337,215
+606
+0.2% +$5.97K ﹤0.01% 2429
2020
Q3
$4.18M Buy
336,609
+10,615
+3% +$141K ﹤0.01% 2161
2020
Q2
$4.24M Buy
325,994
+78,687
+32% +$990K ﹤0.01% 2101
2020
Q1
$2.51M Buy
247,307
+4,499
+2% +$58.7K ﹤0.01% 2181
2019
Q4
$3.8M Buy
242,808
+4,154
+2% +$83.7K ﹤0.01% 2169
2019
Q3
$4.01M Buy
238,654
+131,013
+122% +$2.61M ﹤0.01% 2091
2019
Q2
$2.39M Buy
107,641
+22,368
+26% +$428K ﹤0.01% 2312
2019
Q1
$1.85M Buy
+85,273
New +$1.78M ﹤0.01% 2389

Other funds holding GOSS